Krish Patel, MD

English

Dr. Patel is a dual board-certified hematologist and medical oncologist at SCRI Oncology Partners and the director of lymphoma research at SCRI. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.

Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds.

Dr. Patel recognizes each patient’s illness experience is unique and is focused on providing care that is both evidence-based and personalized to the individual patient. He values the importance of communication in the physician-patient experience and emphasizes shared decision making to help patients navigate their illness and find the support they need. As an experienced sub-specialist with expertise in lymphomas and cellular therapy, Dr. Patel’s goal is to align the individual needs and goals of each patient with the best tools available to achieve those goals. He is passionate about helping advance the standards of treatment through clinical trials that offer patients access to cutting edge therapies.